A New York drugmaker has petitioned the U.S. Supreme Court to overturn lower court rulings that hinder the release of a generic version of a popular diarrhea medication. The company argues that the courts have overreached by siding with patent holders who claim that the generic drug could infringe on existing patents. The case brings into focus the ongoing tension between promoting generic drug availability and protecting patent rights. More details on the case can be found here.